![](/img/cover-not-exists.png)
A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis
Littlewood, James M, Connett, Gary J, Sander-Struckmeier, Suntje, Henniges, FriederikeVolume:
10
Language:
english
Journal:
Expert Opinion on Drug Safety
DOI:
10.1517/14740338.2011.552499
Date:
March, 2011
File:
PDF, 362 KB
english, 2011